The board of directors of Nasdaq-listed company Anixa Biosciences has approved the purchase of Bitcoin as a reserve asset

ChainCatcher news, according to PR Newswire, the NASDAQ-listed company Anixa Biosciences, Inc. (NASDAQ: ANIX) announced that its board has approved the purchase of Bitcoin as a treasury reserve asset, aimed at diversifying the company's assets while allowing Anixa to benefit from the potential long-term value of digital assets.

It is reported that Anixa is a clinical-stage biotechnology company focused on cancer treatment and prevention.